Achondroplasia Treatment Industry Research Report 2023

August 2023 | 80 pages | ID: A21C66BCEAE8EN
APO Research

Abstracts

Achondroplasia is a disorder of bone growth that prevents the changing of cartilage (particularly in the long bones of the arms and legs) to bone. It is characterized by dwarfism, limited range of motion at the elbows, large head size (macrocephaly), small fingers, and normal intelligence. Achondroplasia (ACH) is a rare disease that causes short stature (adult height of approximately 130 cm for males and approximately 125 cm for females) with short limbs. There is no effective treatment available, and this disease is designated as an intractable disease by the Ministry of Health, Labour and Welfare. This disease results mainly from a genetic defect in FGFR3 (fibroblast growth factor type 3 receptor). This genetic change causes the receptor to be overly active to growth factors such as FGF2, which leads to reduced growth of chondrocytes, resulting a short stature. ACH occurs in a frequency of 1 in approximately 25,000 normal live births and is estimated to affect approximately 250,000 people worldwide.

Highlights

The global Achondroplasia Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

The main global Achondroplasia Treatment players include Ascendis Pharma, BioMarin, Ribomic, QED Therapeutics, Pfizer, Astellas, etc. North America is the largest consumer market for Achondroplasia Treatment, accounting for about 46%, followed by Europe and China. In terms of type, CNP Analogue is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Achondroplasia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Achondroplasia Treatment.

The Achondroplasia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Achondroplasia Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Achondroplasia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

• Ascendis Pharma
• BioMarin
• Ribomic
• QED Therapeutics
• Pfizer
• Astellas

Product Type Insights

Global markets are presented by Achondroplasia Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Achondroplasia Treatment are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Achondroplasia Treatment segment by Type

• CNP Analogue
• Ligand Trap
• TKI
• Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Achondroplasia Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Achondroplasia Treatment market.

Achondroplasia Treatment Segment by Application

• Hospital
• Retail Pharmacy
• Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Achondroplasia Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Achondroplasia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Achondroplasia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Achondroplasia Treatment industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Achondroplasia Treatment.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Achondroplasia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

• What factors will challenge the Product Name market growth?
• Which end-use segment will expand at the fastest CAGR in the Product Name market?
• Which are the emerging players in the Product Name market?
• How concentrated is the Product Name market?
• Which factors are positively contributing to the Product Name market growth?
• Which are the novel product innovations in the Product Name market?
• Which product segment will emerge as the most lucrative in the Product Name market?
• Which factors are increasing the competition in the Product Name market?
• Which are the strategic measures taken by the Product Name industry players?
• Which region will witness inactive growth during the forecast period?
• What key trends are likely to emerge in the Product Name market in the coming years?

Contents

LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Achondroplasia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Achondroplasia Treatment Revenue Market Share by Type (2018-2023)
Table 7. Global Achondroplasia Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Achondroplasia Treatment Revenue Market Share by Type (2024-2029)
Table 9. Global Achondroplasia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Achondroplasia Treatment Revenue Market Share by Application (2018-2023)
Table 11. Global Achondroplasia Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Achondroplasia Treatment Revenue Market Share by Application (2024-2029)
Table 13. Global Achondroplasia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Achondroplasia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Achondroplasia Treatment Market Share by Region (2018-2023)
Table 16. Global Achondroplasia Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Achondroplasia Treatment Market Share by Region (2024-2029)
Table 18. Achondroplasia Treatment Market Trends
Table 19. Achondroplasia Treatment Market Drivers
Table 20. Achondroplasia Treatment Market Challenges
Table 21. Achondroplasia Treatment Market Restraints
Table 22. Global Top Achondroplasia Treatment Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Achondroplasia Treatment Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Achondroplasia Treatment Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Achondroplasia Treatment, Headquarters and Area Served
Table 26. Global Achondroplasia Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Achondroplasia Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Achondroplasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Achondroplasia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Achondroplasia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Achondroplasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Achondroplasia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Achondroplasia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Achondroplasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Achondroplasia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Achondroplasia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Achondroplasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Achondroplasia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Achondroplasia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Achondroplasia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Achondroplasia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Achondroplasia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Ascendis Pharma Company Detail
Table 46. Ascendis Pharma Business Overview
Table 47. Ascendis Pharma Achondroplasia Treatment Product
Table 48. Ascendis Pharma Revenue in Achondroplasia Treatment Business (2017-2022) & (US$ Million)
Table 49. Ascendis Pharma Recent Development
Table 50. BioMarin Company Detail
Table 51. BioMarin Business Overview
Table 52. BioMarin Achondroplasia Treatment Product
Table 53. BioMarin Revenue in Achondroplasia Treatment Business (2017-2022) & (US$ Million)
Table 54. BioMarin Recent Development
Table 55. Ribomic Company Detail
Table 56. Ribomic Business Overview
Table 57. Ribomic Achondroplasia Treatment Product
Table 58. Ribomic Revenue in Achondroplasia Treatment Business (2017-2022) & (US$ Million)
Table 59. Ribomic Recent Development
Table 60. QED Therapeutics Company Detail
Table 61. QED Therapeutics Business Overview
Table 62. QED Therapeutics Achondroplasia Treatment Product
Table 63. QED Therapeutics Revenue in Achondroplasia Treatment Business (2017-2022) & (US$ Million)
Table 64. QED Therapeutics Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Achondroplasia Treatment Product
Table 68. Pfizer Revenue in Achondroplasia Treatment Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Astellas Company Detail
Table 71. Astellas Business Overview
Table 72. Astellas Achondroplasia Treatment Product
Table 73. Astellas Revenue in Achondroplasia Treatment Business (2017-2022) & (US$ Million)
Table 74. Astellas Recent Development
Table 75. Ascendis Pharma Company Information
Table 76. Ascendis Pharma Business Overview
Table 77. Ascendis Pharma Achondroplasia Treatment Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million)
Table 78. Ascendis Pharma Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 79. Ascendis Pharma Recent Development
Table 80. BioMarin Company Information
Table 81. BioMarin Business Overview
Table 82. BioMarin Achondroplasia Treatment Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million)
Table 83. BioMarin Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 84. BioMarin Recent Development
Table 85. Ribomic Company Information
Table 86. Ribomic Business Overview
Table 87. Ribomic Achondroplasia Treatment Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million)
Table 88. Ribomic Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 89. Ribomic Recent Development
Table 90. QED Therapeutics Company Information
Table 91. QED Therapeutics Business Overview
Table 92. QED Therapeutics Achondroplasia Treatment Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million)
Table 93. QED Therapeutics Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 94. QED Therapeutics Recent Development
Table 95. Pfizer Company Information
Table 96. Pfizer Business Overview
Table 97. Pfizer Achondroplasia Treatment Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million)
Table 98. Pfizer Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 99. Pfizer Recent Development
Table 100. Astellas Company Information
Table 101. Astellas Business Overview
Table 102. Astellas Achondroplasia Treatment Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million)
Table 103. Astellas Revenue in Achondroplasia Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 104. Astellas Recent Development
Table 105. Authors 12. List of This Report

List Of Figures

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Achondroplasia Treatment Product Picture
Figure 5. Global Achondroplasia Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Achondroplasia Treatment Market Share by Type: 2022 VS 2029
Figure 7. CNP Analogue Product Picture
Figure 8. Ligand Trap Product Picture
Figure 9. TKI Product Picture
Figure 10. Others Product Picture
Figure 11. Global Achondroplasia Treatment Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Achondroplasia Treatment Market Share by Application: 2022 VS 2029
Figure 13. Hospital Product Picture
Figure 14. Retail Pharmacy Product Picture
Figure 15. Others Product Picture
Figure 16. Global Achondroplasia Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Achondroplasia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Achondroplasia Treatment Market Share by Region: 2022 VS 2029
Figure 19. Global Achondroplasia Treatment Market Share by Players in 2022
Figure 20. Global Achondroplasia Treatment Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Achondroplasia Treatment Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Achondroplasia Treatment Market Share by Country (2018-2029)
Figure 25. United States Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Achondroplasia Treatment Market Share by Country (2018-2029)
Figure 29. Germany Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Achondroplasia Treatment Market Share by Country (2018-2029)
Figure 37. China Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Achondroplasia Treatment Market Share by Country (2018-2029)
Figure 45. Mexico Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Achondroplasia Treatment Market Share by Country (2018-2029)
Figure 49. Turkey Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Achondroplasia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Ascendis Pharma Revenue Growth Rate in Achondroplasia Treatment Business (2018-2023)
Figure 53. BioMarin Revenue Growth Rate in Achondroplasia Treatment Business (2018-2023)
Figure 54. Ribomic Revenue Growth Rate in Achondroplasia Treatment Business (2018-2023)
Figure 55. QED Therapeutics Revenue Growth Rate in Achondroplasia Treatment Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Achondroplasia Treatment Business (2018-2023)
Figure 57. Astellas Revenue Growth Rate in Achondroplasia Treatment Business (2018-2023)